本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Recursion Pharmaceuticals, Inc.

3.56
+0.31009.54%
盤後3.54-0.0250-0.70%19:07 EDT
成交量:2,249.06萬
成交額:7,882.95萬
市值:19.05億
市盈率:-3.48
高:3.59
開:3.27
低:3.26
收:3.25
52周最高:7.18
52周最低:2.77
股本:5.35億
流通股本:5.22億
量比:1.06
換手率:4.31%
股息:- -
股息率:- -
每股收益(TTM):-1.0219
每股收益(LYR):-1.4410
淨資產收益率:-56.58%
總資產收益率:-27.33%
市淨率:2.08
市盈率(LYR):-2.47

資料載入中...

2026/06/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/12

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

重要事件披露

Form 8-K - Current report
2026/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/24

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/25

重要事件披露

Form 8-K - Current report
2026/03/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 | RECURSION PHARMACEUTICALS董事Borgeson Blake擬減持170000股,總價約588200美元
2026/02/25

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]